Camille Bedrosian Net Worth & Insider Trades

Camille Bedrosian - EVP and Chief Medical Officer, Ultragenyx Pharmaceutical Inc

As of March 3, 2023

What is Camille Bedrosian's Net Worth?

The current estimated net worth of Ultragenyx Pharmaceutical Inc's EVP and Chief Medical Officer, Camille Bedrosian, is estimated to be about $7.16M . Camille Bedrosian owns about 46,720 units of Ultragenyx Pharmaceutical Inc common stock. In the last 5 years at Ultragenyx Pharmaceutical Inc, Camille Bedrosian has sold an estimated value of $6.29M worth.

What is Camille Bedrosian's Past Insider Trading?

Camille Bedrosian's largest purchase order was 25,000 units , worth over $1.38M on January 19, 2021. Camille Bedrosian's largest sale order was 25,000 units , worth over $3.48M on January 19, 2021. In total, Camille Bedrosian has made about 19 transactions over 5 years of their time at Ultragenyx Pharmaceutical Inc. Camille Bedrosian usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 3,881 units , worth over $175.62K on March 3, 2023.

Camille Bedrosian

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Camille Bedrosian's' Mailing Address?

  • Mailing address is C/o Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 CA

What are Ultragenyx Pharmaceutical Inc's Past Insider Trades?

Ultragenyx Pharmaceutical Inc's most recent insider trade came on March 3, 2023 by Camille Bedrosian who sold 3,881 units worth $175.62K . In the last 9 years, insiders at Ultragenyx Pharmaceutical Inc have sold an estimated value of $121.51M and bought an estimated value of $17.87M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Shalini Sharp, EVP,  Alan Theodore Huizenga, SVP,  and Emil Kakkis, President & CEO .

Ultragenyx Pharmaceutical Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...